Abstract 6071: Role of AKR1B10 inhibition in modulating NSCLC therapy responses
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: University of Missouri
Language: English
Topic: Aldose Reductase and Taurine
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148803444
Cites:
Cited by:
Related to: